Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.
about
Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisPreventive Aspirin and Other Antiplatelet Medication Use Among U.S. Adults Aged ≥ 40 Years: Data from the National Health and Nutrition Examination Survey, 2011-2012.Aspirin Use for the Primary Prevention of Myocardial Infarction Among Men in North Carolina, 2013.Aspirin dosing in cardiovascular disease prevention and management: an update.The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.Compliance with USPSTF recommendations on aspirin for prevention of cardiovascular disease in men.Flavonolignans inhibit the arachidonic acid pathway in blood plateletsAspirin for primary prevention: a challenging decision.Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus.Another Go Around for Aspirin: The Gut Is the Heart of the Matter this Time.Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.Evaluation of aspirin use in patients with diabetes receiving care in community health.Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study
P2860
Q28589784-33144C51-DF41-4A7F-BA74-287F5DBCA0B0Q31021374-3C923E89-507A-47FD-8DE6-AF2055619144Q36305884-3E1CCC6F-A303-46D3-8F5A-56A0DE3F7B8BQ38577514-8AD6F287-CF6D-4D78-A1F8-59C8D1602FF7Q38987249-CD4DA5DF-1521-4FE4-9F3D-DCAC320C9568Q39399361-2C40E45D-A813-43F6-95EF-31E76F3E634EQ41362094-EBF16F3C-AB79-4F54-82A3-FBC335CB5D00Q43123151-6727463A-2675-4774-9ABB-F1182C81BED7Q46055284-C0F48FCD-71B3-4A5E-9201-1A4624EC12A3Q47981301-4B1BD9EB-064C-45FA-9B27-FA0047B70CDAQ48338773-2D21C521-9108-413F-9FE0-10FB638888CFQ51045941-318232E9-3745-44F7-AEFB-E2BF36DEF487Q58715507-C175B28D-489A-4B18-9D12-3D614F649F47
P2860
Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Use of aspirin for primary and ...... the United States, 2011-2012.
@ast
Use of aspirin for primary and ...... the United States, 2011-2012.
@en
type
label
Use of aspirin for primary and ...... the United States, 2011-2012.
@ast
Use of aspirin for primary and ...... the United States, 2011-2012.
@en
prefLabel
Use of aspirin for primary and ...... the United States, 2011-2012.
@ast
Use of aspirin for primary and ...... the United States, 2011-2012.
@en
P2093
P2860
P356
P1476
Use of aspirin for primary and ...... the United States, 2011-2012.
@en
P2093
Arch G Mainous
Marian C Limacher
Rebecca J Tanner
Ronald I Shorr
P2860
P356
10.1161/JAHA.114.000989
P577
2014-07-14T00:00:00Z